Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations

The Oncologist
Benjamin P LevyFred R Hirsch

Abstract

The recent discovery of relevant biomarkers has reshaped our approach to therapy selection for patients with non-small cell lung cancer. The unprecedented outcomes demonstrated with tyrosine kinase inhibitors in molecularly defined cohorts of patients has underscored the importance of genetic profiling in this disease. Despite published guidelines on biomarker testing, successful tumor genotyping faces significant hurdles at both academic and community-based practices. Oncologists are now faced with interpreting large-scale genomic data from multiple tumor types, possibly making it difficult to stay current with practice standards in lung cancer. In addition, physicians' lack of time, resources, and face-to-face opportunities can interfere with the multidisciplinary approach that is essential to delivery of care. Finally, several challenges exist in optimizing the amount and quality of tissue for molecular testing. Recognizing the importance of biomarker testing, a series of advisory boards were recently convened to address these hurdles and clarify best practices. We reviewed these challenges and established recommendations to help optimize tissue acquisition, processing, and testing within the framework of a multidisciplinary...Continue Reading

References

Jun 1, 1995·Seminars in Oncology·P A Bunn, K Kelly
Jan 11, 2002·The New England Journal of Medicine·Joan H SchillerUNKNOWN Eastern Cooperative Oncology Group
Feb 9, 2002·The Annals of Thoracic Surgery·Masaaki SatoHiromi Wada
Feb 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David A EberhardUNKNOWN Non-Small-Cell Lung Cancer Working Group
May 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio Vittorio ScagliottiDavid Gandara
Feb 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Akira InoueUNKNOWN North East Japan Gefitinib Study Group
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Oct 12, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fred R HirschPaul A Bunn
Jan 22, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·William D TravisDavid Yankelewitz
Jan 27, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Natasha RekhtmanAndre L Moreira
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul A Bunn, Robert C Doebele
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Geoffrey R OxnardPasi A Jänne
Aug 21, 2013·American Journal of Respiratory and Critical Care Medicine·Mina GagaUNKNOWN ATS/ERS Task Force on the Role of the Pulmonologist in the Management of Lung Cancer
Nov 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward H WagnerRuth McCorkle
Jan 1, 2014·Clinical Lung Cancer·George R Simon, Neeta Somaiah
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
May 23, 2014·JAMA : the Journal of the American Medical Association·Mark G KrisPaul A Bunn
Dec 4, 2014·The New England Journal of Medicine·Benjamin J SolomonUNKNOWN PROFILE 1014 Investigators

❮ Previous
Next ❯

Citations

Nov 1, 2016·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Diane M KorngiebelWylie Burke
Sep 27, 2016·Journal of Managed Care & Specialty Pharmacy·Reshma ShindeSmita Kothari
Dec 23, 2017·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Hua-Li LiuQi-Bin Song
Nov 16, 2018·Journal of Medical Economics·James SignorovitchAnita Chawla
Jan 7, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jennifer L Hunt
Oct 11, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P GarridoF López-Ríos
Dec 17, 2017·Chest·Septimiu MurguUNKNOWN GAIN collaborators
May 24, 2020·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Matthew P SmeltzerFred R Hirsch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.